| Microneedles in the clinic S Bhatnagar, K Dave, VVK Venuganti Journal of Controlled Release 260, 164–182, 2017 | 277 | 2017 |
| Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules S Choudhary, L Gupta, S Rani, K Dave, U Gupta Frontiers in pharmacology 8, 261, 2017 | 200 | 2017 |
| FDA approval summary: niraparib for the maintenance treatment of patients with recurrent ovarian cancer in response to platinum-based chemotherapy G Ison, LJ Howie, L Amiri-Kordestani, L Zhang, S Tang, R Sridhara, ... Clinical Cancer Research 24 (17), 4066-4071, 2018 | 113 | 2018 |
| Compositions and methods for localized drug delivery through mammary papillae OP Perumal, K Dave, C Dwivedi, S Santha US Patent 9,220,680, 2015 | 59 | 2015 |
| Dendritic polymers for dermal drug delivery K Dave, VV Krishna Venuganti Therapeutic delivery 8 (12), 1077-1096, 2017 | 42 | 2017 |
| Chemoprevention of breast cancer by transdermal delivery of α-santalol through breast skin and mammary papilla (nipple) K Dave, FM Alsharif, S Islam, C Dwivedi, O Perumal Pharmaceutical research 34, 1897-1907, 2017 | 35 | 2017 |
| Transpapillary drug delivery to the breast K Dave, R Averineni, P Sahdev, O Perumal PLoS One 9 (12), e115712, 2014 | 32 | 2014 |
| Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis G Singh, B Ghosh, D Kaushalkumar, V Somsekhar AAPS PharmSciTech 9 (3), 791-797, 2008 | 31 | 2008 |
| Feasibility of Focused Beam Reflectance Measurement (FBRM) for Analysis of Pharmaceutical Suspensions in Preclinical Development K Dave, PE Luner, C Forness, D Baker, C Jankovsky, S Chen AAPS PharmSciTech, 1-11, 2017 | 18 | 2017 |
| Transpapillary (nipple) delivery of macromolecules to the breast: proof of concept study K Dave, FM Alsharif, O Perumal Molecular pharmaceutics 13 (11), 3842-3851, 2016 | 15 | 2016 |
| Impact of dendrimers on solubility of hydrophobic drug molecules. Front Pharmacol. 2017; 8: 261 S Choudhary, L Gupta, S Rani, K Dave, U Gupta | 14 | 2017 |
| Influence of Hydroalcoholic Vehicle on In Vitro Transport of 4-Hydroxy Tamoxifen Through the Mammary Papilla (Nipple) FM Alsharif, K Dave, AM Samy, KI Saleh, MA Amin, O Perumal AAPS PharmSciTech 18, 1366-1373, 2017 | 12 | 2017 |
| Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis TD La Count, Q Zhang, M Murawsky, J Hao, P Ghosh, K Dave, SG Raney, ... The AAPS journal 22, 1-14, 2020 | 8 | 2020 |
| Assessment of applications of design of experiments in pharmaceutical development for oral solid dosage forms G Bai, Z Chen, K Raines, H Chen, K Dave, HP Lin, BS Zolnik Journal of Pharmaceutical Innovation 15, 547-555, 2020 | 7 | 2020 |
| Synthesis and evaluation of esmolol prodrugs for transdermal delivery G Bijaya, D Kaushal, D Sonal, K Pallavi Drug Delivery 17 (7), 532-540, 2010 | 7 | 2010 |
| Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed … N Ahmed, H Ly, A Pan, B Chiang, K Raines, T Janwatin, S Hamed, ... European Journal of Pharmaceutics and Biopharmaceutics 193, 294-305, 2023 | 3 | 2023 |
| A Review of In-Vitro Drug Release Methodologies for Topical and Transdermal Systems/Patches provided in NDA and ANDA Submissions to the US-FDA K Dave, O Anand, E Chikhale, O Eradiri, A Dorantes 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
| Topical Drug Delivery to the Breast K Dave South Dakota State University, 2015 | | 2015 |
| 65th FLAX INSTITUTE OF THE UNITED STATES H Inn | | 2014 |
| South Dakota State University, Winter 2014 C Delfanian, E Landwehr Office of University Relations, South Dakota State University, 2014 | | 2014 |
